Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study

Frontiers in Pharmacology

Volumn 7, Issue SEP, 2016, Pages

  Mozurkewich, Ellen L ^a,b   Greenwood, Matthew ^c   Clinton, Chelsea ^d   Berman, Deborah ^b   Romero, Vivian ^e   Djuric, Zora ^b   Qualls, Clifford ^f   Gronert, Karsten ^c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

DHA; EPA; Resolvins

Indexed keywords

14 HYDROXY DOCOSAHEXAENOIC ACID; 17 HYDROXY DOCOSAHEXAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MARESIN; MEDIATOR COMPLEX; RESOLVIN; SOYBEAN OIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IN VIVO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MATERNAL BLOOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD;

EID: 84991738593     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00274     Document Type: Article

References (36)

1. Baack, M. L., Puumala, S. E., Messier, S. E., Pritchett, D. K., and Harris, W. S. (2015). What is the relationship between gestational age and docosahexaenoic acid (DHA) and arachidonic acid (ARA) levels? Prostaglandins Leukot. Essent. Fatty Acids 100, 5-11. doi: 10.1016/j.plefa.2015.05.003
2. Barden, A., Mas, E., Croft, K. D., Phillips, M., and Mori, T. A. (2014). Short-term n-3 fatty acid supplementation but not aspirin increases plasma pro-resolving mediators of inflammation. J. Lipid Res. 55, 2401-2407. doi: 10.1194/jlr.M045583
3. Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., and Serhan, C. N. (2014). Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell Physiol. 307, C39-C54. doi: 10.1152/ajpcell.00024.2014
4. Delarue, J., Li, C., Cohen, R., Corporeau, C., and Simon, B. (2006). Interaction of fish oil and a glucocorticoid on metabolic responses to an oral glucose load in healthy human subjects. Br. J. Nutr. 95, 267-272. doi: 10.1079/BJN20051631
5. Fredman, G., and Serhan, C. N. (2011). Specialized pro-resolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem. J. 437, 185-197. doi: 10.1042/BJ20110327
6. Gomolka, B., Siegert, E., Blossey, K., Schunck, W., Rothe, M., and Weylandt, K. H. (2011). Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Prostaglandins Other Lipid Mediat. 94, 81-87. doi: 10.1016/j.prostaglandins.2010.12.006
7. Gonzalez, J. M., Dong, Z., Romero, R., and Girardi, G. (2011). Cervical remodeling/ripening at term and preterm delivery: the same mechanism initiated by different mediators and different effector cells. PLoS ONE 6:e26877. doi: 10.1371/journal.pone.0026877
8. González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., et al. (2009). Obesity-induced insulin resistance and hepatic steatosis are alleviated by ?-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946-1957. doi: 10.1096/fj.08-125674
9. Gonzalez-Periz, A., Planaguma, A., Gronert, K., Miquel, R., Lopez-Parra, M., Titos, E., et al. (2006). Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20, 2537-2539. doi: 10.1096/fj.06-6250fje
10. Grenon, S. M., Owens, C. D., Nosova, E. V., Hughes-Fulford, M., Alley, H. F., Chong, K., et al. (2015). Short-Term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I Trial). J. Am. Heart Assoc. 4:e002034. doi: 10.1161/JAHA.115.002034
11. Gronert, K. (2008). Lipid autacoids in inflammation and injury responses: a matter of privilege. Mol. Interv. 8, 28-35. doi: 10.1124/mi.8.1.7
12. Hassan, I. R., and Gronert, K. (2009). Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 182, 3223-3232. doi: 10.4049/jimmunol.0802064
13. Hellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., and Spite, M. (2011). Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25, 2399-2407. doi: 10.1096/fj.10-178657
14. Horvath, A., Koletzko, B., and Szajewska, H. (2007). Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br. J. Nutr. 98, 253-259. doi: 10.1017/S0007114507709078
15. Jones, M. L., Mark, P. J., Keelan, J. A., Barden, A., Mas, E., Mori, T. A., et al. (2013). Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J. Lipid Res. 54, 2247-2254. doi: 10.1194/jlr.M039842
16. Kalish, B. T., Le, H. D., Fitzgerald, J. M., Wang, S., Seamon, K., Gura, K. M., et al. (2013). Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory pro-resolving lipid mediators. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G818-G828. doi: 10.1152/ajpgi.00106.2013
17. Keelan, J. A., Mas, E., D'Vaz, N., Dunstan, J. A., Li, S., Barden, A. E., et al. (2015). Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149, 171-178. doi: 10.1530/REP-14-0549
18. Makrides, M., Duley, L., and Olsen, S. F. (2006). Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst. Rev. 3:CD003402. doi: 10.1002/14651858.CD003402
19. Makrides, M., Gibson, R. A., McPhee, A. J., Yelland, L., Quinlivan, J., Ryan, P., et al. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 304, 1675-1683. doi: 10.1001/jama.2010.1507
20. Mas, E., Barden, A., Burke, V., Beilin, L. J., Watts, G. F., Huang, R. C., et al. (2016). A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin. Nutr. 35, 331-336. doi: 10.1016/j.clnu.2015.04.004
21. Miyata, J., Fukunaga, K., Iwamoto, R., Isobe, Y., Niimi, K., Takamiya, R., et al. (2013). Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J. Allergy Clin. Immunol. 131, 353-360. doi: 10.1016/j.jaci.2012.07.048
22. Morris, T., Stables, M., Colville-Nash, P., Newson, J., Bellingan, G., de Souza, P. M., et al. (2010). Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc. Natl. Acad. Sci. U.S.A. 107, 8842-8847. doi: 10.1073/pnas.1000373107
23. Mozurkewich, E. L., Clinton, C. M., Chilimigras, J. L., Hamilton, S. E., Allbaugh, L. J., Berman, D. R., et al. (2013). The mothers, omega-3, and mental health study: a double-blind, randomized controlled trial. Am. J. Obstet. Gynecol. 208, 313. doi: 10.1016/j.ajog.2013.01.038
24. Murphy, R. C. (2015). Specialized pro-resolving mediators: do they circulate in plasma? J. Lipid Res. 56, 1641-1642. doi: 10.1194/jlr.C062356
25. Pruss, H., Rosche, B., Sullivan, A. B., Brommer, B., Wengert, O., Gronert, K., et al. (2013). Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PLoS ONE 8:e55859. doi: 10.1371/journal.pone.0055859
26. Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., et al. (2011). The human serum metabolome. PLoS ONE 6:e16957. doi: 10.1371/journal.pone.0016957
27. Sapieha, P., Stahl, A., Chen, J., Seaward, M. R., Willett, K. L., Krah, N. M., et al. (2011). 5-Lipoxygenase metabolite 4-HDHA Is a mediator of the antiangiogenic effect of ?-3 polyunsaturated fatty acids. Sci. Transl. Med. 3, 69ra12. doi: 10.1126/scitranslmed.3001571
28. Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101. doi: 10.1038/nature13479
29. Serhan, C. N., Chiang, N., and Dalli, J. (2015). The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin. Immunol. 27, 200-215. doi: 10.1016/j.smim.2015.03.004
30. Serhan, C. N., and Petasis, N. A. (2011). Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 5922-5943. doi: 10.1021/cr100396c
31. Skarke, C., Alamuddin, N., Lawson, J. A., Li, X., Ferguson, J. F., Reilly, M. P., et al. (2015). Bioactive products formed in humans from fish oils. J. Lipid Res. 56, 1808-1820. doi: 10.1194/jlr.M060392
32. Szajewska, H., Horvath, A., and Koletzko, B. (2006). Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 83, 1337-1344.
33. von Moltke, J., Trinidad, N. J., Moayeri, M., Kintzer, A. F., Wang, S. B., van Rooijen, N., et al. (2012). Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107-111. doi: 10.1038/nature11351
34. Weiss, G. A., Troxler, H., Klinke, G., Rogler, D., Braegger, C., and Hersberger, M. (2013). High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health. Dis. 12:89. doi: 10.1186/1476-511X-12-89
35. Weylandt, K. H., Chiu, C. Y., Gomolka, B., Waechter, S. F., and Wiedenmann, B. (2012). Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 97, 73-82. doi: 10.1016/j.prostaglandins.2012.01.005
36. Yamashita, A., Kawana, K., Tomio, K., Taguchi, A., Isobe, Y., Iwamoto, R., et al. (2013). Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. Sci. Rep. 3:3113. doi: 10.1038/srep03113